Forest Labs Subpoenaed Over Hypertension Meds

Law360, New York (May 9, 2011, 8:19 PM EDT) -- Forest Laboratories Inc. said Monday it had received a subpoena from the U.S. attorney's office in Massachusetts seeking information related to hypertension treatment medications.

U.S. Attorney Carmen Ortiz’s office sent an April 20 subpoena to the New York-based company with requests to turn over documents involving its Benicar, Benicar HCT and Azor drugs, Forest said in a statement. Forest and Benicar’s originator, Daiichi Sankyo Inc., co-marketed the drug from 2002 through 2008.

“The company intends to cooperate in responding to the subpoena,” Forest said.

Forest’s announcement...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.